GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,192,000 | +58.7% | 115,638 | -3.1% | 3.74% | +46.2% |
| Q3 2019 | $5,792,000 | -3.9% | 119,372 | +4.2% | 2.56% | +7.9% |
| Q2 2019 | $6,026,000 | -5.6% | 114,562 | -5.0% | 2.37% | +8.3% |
| Q1 2019 | $6,383,000 | +102.2% | 120,594 | +56.8% | 2.19% | +120.5% |
| Q4 2018 | $3,157,000 | -1.8% | 76,899 | -9.1% | 0.99% | +10.2% |
| Q3 2018 | $3,214,000 | -40.1% | 84,579 | -28.8% | 0.90% | -49.3% |
| Q2 2018 | $5,369,000 | +116.2% | 118,775 | +131.0% | 1.78% | +45.9% |
| Q1 2018 | $2,483,000 | +23.0% | 51,412 | +0.2% | 1.22% | +40.3% |
| Q4 2017 | $2,019,000 | – | 51,301 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |